FENC
Fennec Pharmaceuticals Inc.
Approval
Confirmed
PEDMARK
reduce the risk of ototoxicity associated with cisplatin in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors
1376d ago
~ Sep 30, 2022
SEC 8-K
verified 14h ago
Countdown card →